Investing Profile

Karl Rothweiler

InvestorVC
Managing Partner at Aglaia Oncology Funds
Photo of Karl Rothweiler, Managing Partner at Aglaia Oncology Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Quick Wins Network
209 CONNECTIONS
Quick Wins Network
209 CONNECTIONS
Capgemini Network
36 CONNECTIONS
The University of Georgia Network
20 CONNECTIONS
Aglaia Oncology Funds Managing Partner
$100K - $5.0M
$1.5M
Founding Investor, Member of the Supervisory Board Inthera Bioscience AG2022 - Present
Founder, Founding Investor, Member of the Supervisory Board Sapreme Technologies BV2016 - Present
Founding Investor, Member of the Supervisory Board Modra Pharmaceuticals2015 - Present
Founding Investor Merus N.V.2005 - Present
Managing Partner Aglaia Oncology Funds2004 - Present
Founding Investor, Member of the Supervisory Board Quick WinsPresent
Founder, Founding Investor, Member of the Supervisory Board Quick WinsPresent
Founder, Founding Investor, Member of the Supervisory Board InteRNA Technologies BV2006 - 2023
Founder, Founding Investor, Member of the Supervisory Board ISA Pharmaceuticals2004 - 2017
Founder, Founding Investor ORCA Therapeutics2005 - 2013
Founding Investor, Member of the Supervisory Board Syntarga2005 - 2011
Founder Entity Holding1995 - 2004
Director Finance Division Capgemini1990 - 1995
Commercial Manager Volmac1983 - 1990
The University of Georgia MBA Business
Nyenrode New Business School BBA Business
Fioretti College
--
Sign in with Google →
Sign in with Google →